Impact of Cardiac Complications on Outcomes of Patients After Subarachnoid Hemorrhage

November 23, 2019 updated by: Reda Omar, Assiut University
Patients with subarachnoid haemorrhage frequently develop cardiac complications affecting their outcome

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

50

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients presented with spontaneous subarachnoid hemorrhage admitted to our department included in this study

Description

Inclusion Criteria:

  • Patients diagnosed as spontaneous subarachnoid hemorrhage.
  • SSAH patients aged (18-70 years) of both sexes

Exclusion Criteria:

  • History or current evidence of any CNS disease other than SAH which may cause cardiac complications.
  • History or current evidence of medical illness as endocrinal and metabolic disorders which may cause cardiac complications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Electrocadriogram
Time Frame: 1 miute
to measure heart rate (beats/minute) in subarachnoid hemorrhage patients
1 miute
Echocardiogarphy
Time Frame: 30 minute
to measure ejection fraction (%) in subarachnoid hemorrhage patients
30 minute

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
serum treponin level
Time Frame: 30 minute
to measure serum treponin(ng/ml)in subarachnoid hemorrhage patients
30 minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

December 1, 2019

Primary Completion (ANTICIPATED)

May 31, 2020

Study Completion (ANTICIPATED)

December 1, 2020

Study Registration Dates

First Submitted

September 23, 2019

First Submitted That Met QC Criteria

November 23, 2019

First Posted (ACTUAL)

November 26, 2019

Study Record Updates

Last Update Posted (ACTUAL)

November 26, 2019

Last Update Submitted That Met QC Criteria

November 23, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Impact of cardiac complication

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Subarachnoid Hemorrhage

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe